THE CLINICAL VALUE OF DETECTING GENE REARRANGEMENT IN ACUTE LEUKAMIAS:
- 1 November 1994
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 88 (3) , 459-464
- https://doi.org/10.1111/j.1365-2141.1994.tb05060.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of inductionThe Lancet, 1994
- Detection of ALL-1/AF4 fusion transcript by reverse transcription- polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocationBlood, 1993
- Rearrangement of the MLL Gene in Acute Lymphoblastic and Acute Myeloid Leukemias with 11q23 Chromosomal TranslocationsNew England Journal of Medicine, 1993
- Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid LeukemiaScience, 1993
- Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reactionBlood, 1992
- Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemiaBlood, 1992
- Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia.Journal of Clinical Investigation, 1991
- Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reactionThe Lancet, 1991
- Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19).Journal of Clinical Oncology, 1990
- Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.Proceedings of the National Academy of Sciences, 1989